• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research.

作者信息

Strawn Jeffrey R, Croarkin Paul E

机构信息

1 Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati , Cincinnati, Ohio.

2 Department of Psychiatry and Psychology, Mayo Clinic , Rochester, Minnesota.

出版信息

J Child Adolesc Psychopharmacol. 2018 Jun;28(5):363. doi: 10.1089/cap.2018.0012. Epub 2018 Apr 5.

DOI:10.1089/cap.2018.0012
PMID:29620924
Abstract
摘要

相似文献

1
Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research.在一项以氟西汀为对照的重度抑郁症儿童和青少年研究中，去甲文拉法辛与安慰剂的对比：儿童和青少年精神药理学研究的设计、定义及持续挑战
J Child Adolesc Psychopharmacol. 2018 Jun;28(5):363. doi: 10.1089/cap.2018.0012. Epub 2018 Apr 5.
2
Re: "Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research" by Strawn JR and Croarkin PE (J Child Adolesc Psychopharmacol 2018;28:(5)363).回复：斯特劳恩（JR Strawn）和克罗尔金（PE Croarkin）所著的《在以氟西汀为对照的重度抑郁症儿童和青少年研究中去甲文拉法辛与安慰剂的对比：儿童和青少年精神药理学研究的设计、定义及持续挑战》（《儿童与青少年精神药理学杂志》2018年；28:（5）363）
J Child Adolesc Psychopharmacol. 2019 Apr;29(3):245-246. doi: 10.1089/cap.2018.0163. Epub 2019 Mar 15.
3
Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.在一项以氟西汀为对照的重度抑郁症儿童和青少年研究中，去甲文拉法辛与安慰剂的对比
J Child Adolesc Psychopharmacol. 2018 Feb;28(1):36-46. doi: 10.1089/cap.2017.0100. Epub 2017 Nov 30.
4
Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability.5-羟色胺-去甲肾上腺素再摄取抑制剂治疗儿童和青少年重度抑郁症的随机对照试验：疗效与可接受性的荟萃分析
Braz J Med Biol Res. 2016 May 24;49(6). doi: 10.1590/1414-431X20164806.
5
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.度洛西汀与安慰剂治疗儿童和青少年重度抑郁症的对比研究
J Child Adolesc Psychopharmacol. 2018 Feb;28(1):55-65. doi: 10.1089/cap.2017.0099. Epub 2017 Nov 29.
6
Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline.在重度抑郁症患者中，按年龄组和基线时抑郁严重程度比较度洛西汀与安慰剂的疗效。
J Clin Psychopharmacol. 2017 Apr;37(2):182-192. doi: 10.1097/JCP.0000000000000674.
7
Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive Disorder.单剂量递增给予患有重度抑郁症的儿童和青少年去甲文拉法辛的药代动力学和耐受性
J Child Adolesc Psychopharmacol. 2016 Dec;26(10):909-921. doi: 10.1089/cap.2016.0009. Epub 2016 Jul 18.
8
[Economic evaluation of desvenlafaxine in the treatment of major depressive disorder in Spain].[度洛西汀治疗西班牙重度抑郁症的经济学评估]
Rev Psiquiatr Salud Ment. 2016 Apr-Jun;9(2):87-96. doi: 10.1016/j.rpsm.2015.08.002. Epub 2015 Oct 21.
9
Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials.度洛西汀治疗儿童和青少年重性抑郁障碍的安全性、耐受性和疗效：两项开放标签扩展试验结果。
CNS Spectr. 2019 Oct;24(5):496-506. doi: 10.1017/S1092852918001128.
10
Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.50毫克和100毫克去甲文拉法辛与安慰剂对重度抑郁症患者性功能的影响：一项荟萃分析。
Int Clin Psychopharmacol. 2015 Nov;30(6):307-15. doi: 10.1097/YIC.0000000000000094.

引用本文的文献

1
Retrospective analysis of clinical characteristics and treatment of children and adolescents with depression.儿童和青少年抑郁症临床特征及治疗的回顾性分析
Front Psychiatry. 2023 Jul 27;14:1036314. doi: 10.3389/fpsyt.2023.1036314. eCollection 2023.
2
The Impact of Failed Antidepressant Trials on Outcomes in Children and Adolescents with Anxiety and Depression: A Systematic Review and Meta-Analysis.抗抑郁药试验失败对儿童和青少年焦虑和抑郁结局的影响：系统评价和荟萃分析。
J Child Adolesc Psychopharmacol. 2021 May;31(4):259-267. doi: 10.1089/cap.2020.0195. Epub 2021 Apr 21.
3
A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up.
一项随机、双盲、安慰剂对照的维拉佐酮治疗伴有 26 周开放性标签随访的儿童和青少年重性抑郁障碍的临床试验。
J Child Adolesc Psychopharmacol. 2020 Jul;30(6):355-365. doi: 10.1089/cap.2019.0176. Epub 2020 May 27.
4
Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents.针对青少年重度抑郁症修订的患者健康问卷-9的心理测量特性。
J Child Adolesc Psychopharmacol. 2019 Feb;29(1):34-40. doi: 10.1089/cap.2018.0112. Epub 2018 Nov 2.